Here are the top 5 articles from 2024 reported on Oncology Nursing News. Opinion: The Media May Have Oversold AOH1996, City ...

Hologic took on considerable leverage after its $3.8 billion acquisition of Gen-Probe in 2012, but deleveraged in the ensuing years and avoided piling on more debt for the purchase of Cynosure. As of ...

Q: Many of my relatives are getting really old — they seem to be able to live a very long life — but they’re not thriving, ...

With the addition of these two new assay launches, Zomedica has added 8 new assays in the past 18 months to the rapidly growing TRUFORMA Platform ...

Shares of Hologic, Inc. (NASDAQ:HOLX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the fifteen analysts that are presently covering the firm, Marketbeat ...

In Kashmir, lifestyle changes are helping cervical cancer cases rise, years after cultural factors limited incidence ...

With the addition of these two new assay launches, Zomedica has added 8 new assays in the past 18 months to the rapidly growing TRUFORMA Platform ANN ARBOR, MI / ACCESSWIRE / December 23, 2024 / Zomed ...

First and only EGFR inhibitor and targeted treatment approved in the EU in unresectable NSCLC . Approval based on LAURA Phase III trial results which showed Tagrisso extended medi ...